Terrie Curran, Director: Arcutis Biotherapeutics ARQT Sell · Filed 24/11/13

Trade details

Type: Insider sale
Amount: $94,253.95
Shares · price: 8,687 sh · $10.85 a share
Held after: 10,139 sh
Stock: Arcutis Biotherapeutics ARQT
Person: Terrie CurranDirector
Trade date: 24/11/11
Filed: 24/11/13
Days to filing: 2 days

Sold 46.1% of holdings

Share of holding sold: 46.1%

Arcutis Biotherapeutics trades, last 26 weeks

What else happened in Arcutis Biotherapeutics around then

Filed or reported within 30 days of the trade day · 24/10/12~24/12/11

Terrie Curran's recent trades

Terrie CurranDirector
Planned saleArcutis Biotherapeutics
Planned sale
Arcutis Biotherapeutics
ARQT
$956.1K
38,200 sh
$956.1K
Filed 08/27
Traded 08/27
Terrie CurranDirector
Planned saleArcutis Biotherapeutics
Planned sale
Arcutis Biotherapeutics
ARQT
$27.9K
1,072 sh
$27.9K
Filed 08/20
Traded 08/20
Terrie CurranPresident and Chief Executive
SellPhathom Pharmaceuticals
Sell
Phathom Pharmaceuticals
PHAT
$125.9K
19,109 sh
$125.9K
Filed 25/01/23
Traded 25/01/21
Terrie CurranPresident and Chief Executive
SellPhathom Pharmaceuticals
Sell
Phathom Pharmaceuticals
PHAT
$396.7K
33,848 sh
$396.7K
Filed 24/07/17
Traded 24/07/15
Terrie CurranPresident and Chief Executive
SellPhathom Pharmaceuticals
Sell
Phathom Pharmaceuticals
PHAT
$153.5K
16,851 sh
$153.5K
Filed 24/03/26
Traded 24/03/22